KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
82 hedge funds and large institutions have $301M invested in Chinook Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
–
Holders Change %
0%
% of All Funds
2.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
42
Reduced
20
Closed
12
Calls
$803K
Puts
$117K
Net Calls
+$686K
Net Calls Change
-$117K
Top Buyers
| 1 |
O
OppenheimerFunds
New York
|
+$9.3M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$3.42M |
| 3 |
JPMorgan Chase & Co
New York
|
+$3.14M |
| 4 |
BlackRock
New York
|
+$2.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.58M |
Top Sellers
| 1 |
GTC
Ghost Tree Capital
New York
|
-$8.6M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.21M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.88M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$845K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$633K |
